De-escalation of anti-platelet therapy in patients with acute coronary syndromes undergoing percutaneous coronary intervention-Reference-Cited by-同舟云学术

De-escalation of anti-platelet therapy in patients with acute coronary syndromes undergoing percutaneous coronary intervention

Published:2019-01-20 Issue:2 Volume:132 Page:197-210
ISSN:0366-6999
Container-title:Chinese Medical Journal
language:en
Short-container-title:

Author:

Han Ya-Ling

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference100 articles.

1. Heart disease and stroke statistics-2017 Update: a report from the American Heart Association;Benjamin;Circulation,2017

2. Mechanisms of acute coronary syndromes and their implications for therapy;Libby;N Engl J Med,2013

3. Platelet activation and atherothrombosis;Davì;N Engl J Med,2007

4. Basic principles of platelet biology and clinical implications;Angiolillo;Circ J,2010

5. 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines and the Society for Cardiovascular Angiography and Interventions;Levine;Circulation,2011

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In-hospital outcomes of anemic patients with acute coronary syndrome receiving ticagrelor versus clopidogrel: Results of the Chinese Cardiovascular Care Improvement (CCC)-Acute Coronary Syndrome Project;Chinese Medical Journal;2024-09-05

2. Prognostic Analysis and an Appropriate Antiplatelet Strategy for Patients With Percutaneous Coronary Intervention and High Bleeding Risk: Rationale and Protocol for a Multi-Center Cohort Study;Cardiology Discovery;2024-03-27

3. De-escalation of Antiplatelet Therapy After Percutaneous Coronary Intervention in East Asian Patients With Acute Coronary Syndrome;Clinical Therapeutics;2023-12

4. Pharmacogenomic evaluation of CYP2C19 alleles linking low clopidogrel response and the risk of acute coronary syndrome in Indians;The Journal of Gene Medicine;2023-11-20

5. Comparison of Ticagrelor Monotherapy and Ticagrelor Plus Aspirin Among Patients With Acute Coronary Syndrome Combined With High-Risk of Gastrointestinal Bleeding After Percutaneous Coronary Intervention: A Retrospective Cohort Study;Journal of Cardiovascular Pharmacology;2023-09-29